[Crystepin CH. A multi-centre trial of an antihypertensive drug (author's transl)]. 1981

O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D002752 Chlorthalidone A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic. Chlorphthalidolone,Phthalamudine,Chlortalidone,Hygroton,Oxodoline,Thalitone
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003005 Clopamide A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic. Brinaldix,Brinedine
D004088 Dihydroergotoxine A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES. Co-Dergocrine,Ergot Alkaloids, Hydrogenated,Dihydroergotoxin,Alkaloids, Hydrogenated Ergot,Hydrogenated Ergot Alkaloids
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females

Related Publications

O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
January 1976, Arzneimittel-Forschung,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
April 1977, Deutsche medizinische Wochenschrift (1946),
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
January 1976, Folia clinica internacional,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
April 1976, Ceskoslovenska gynekologie,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
August 1990, Journal of human hypertension,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
July 1977, Medizinische Klinik,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
November 1980, Deutsche medizinische Wochenschrift (1946),
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
July 1980, Therapeutische Umschau. Revue therapeutique,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
January 1979, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
O Mayer, and V Cepelák, and M Blazek, and J Cerný, and R Niebauer, and V Kokaisl, and M Koznarová, and A Mádle, and J Mazanec, and K Moses, and A Munzarová, and Z Cícha, and J Vácha
October 1973, Wiener klinische Wochenschrift,
Copied contents to your clipboard!